Corbus Pharmaceuticals Holdings, Inc. SEC filings CRBP
Corbus Pharmaceuticals Holdings, Inc. has 808 filings in SEC EDGAR's recent list, going back to Jan 10, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 18, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2026 | — |
| EFFECT | Filing | Mar 20, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2024 | — |
| EFFECT | Filing | Jun 13, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| 8-A12G | Filing | Oct 12, 2022 | — |
| EFFECT | Filing | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 30, 2020 | — |
| CORRESP | Letter to the SEC | Apr 24, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2019 | — |
| CORRESP | Letter to the SEC | Jun 25, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2019 | — |
| CT ORDER | Filing | Mar 4, 2019 | — |
| CT ORDER | Filing | Dec 4, 2018 | — |
| CT ORDER | Filing | Apr 25, 2018 | — |
| EFFECT | Filing | Jan 17, 2018 | — |
| CORRESP | Letter to the SEC | Jan 16, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 11, 2018 | — |
| EFFECT | Filing | Sep 13, 2016 | — |
| EFFECT | Filing | Nov 19, 2015 | — |
| CORRESP | Letter to the SEC | Nov 18, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2015 | — |
| CT ORDER | Filing | Jun 18, 2015 | — |
| CERTNAS | Auto-generated paper document | Apr 15, 2015 | — |
| 8-A12B | Form 8-a | Apr 14, 2015 | — |
| EFFECT | Filing | Apr 6, 2015 | — |
| 8-A12G | Filing | Nov 25, 2014 | — |
| CT ORDER | Filing | Oct 7, 2014 | — |
| EFFECT | Filing | Oct 3, 2014 | — |
| CORRESP | Letter to the SEC | Oct 2, 2014 | — |
| CORRESP | Letter to the SEC | Oct 2, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2014 | — |
| CORRESP | Letter to the SEC | Sep 30, 2014 | — |
| CORRESP | Letter to the SEC | Sep 30, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2014 | — |
| CORRESP | Letter to the SEC | Sep 3, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2014 | — |
| DRSLTR | Filing | Aug 12, 2014 | — |
| DRS/A | Filing | Aug 12, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2014 | — |
| DRS | Filing | Jul 2, 2014 | — |
| D | Filing | Apr 23, 2014 | — |
| D | Filing | Mar 12, 2014 | — |
| D | Filing | Jan 10, 2014 | — |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595097
- Former names
- SAV Acquisition Corp (until Jan 10, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.